COMMUNIQUÉS West-GlobeNewswire

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
07/05/2019
WALTHAM, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,279,179 titled “Transcutaneous Electrical Nerve [...]
Medexus Pharmaceuticals Launches New Metoject® Subcutaneous 15mg Dosage for the Treatment of Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis in Canada
07/05/2019
MONTREAL, May 07, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), today announced the launch of a new Metoject® Subcutaneous 15mg dose in Canada. Metoject [...]
ORION CORPORATION: ACQUISITION OF OWN SHARES 07.05.2019
07/05/2019
Orion Corporation NOTIFICATION 07.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 07.05.2019 Date 07.05.2019 Exchange transaction Buy Share class ORNBV Amount 30,832 Average price/share 29.6153 EUR Highest [...]
Dermatologists Say Sunscreen is a Vital Tool in the Fight Against Skin Cancer, the Most Common Cancer in the U.S.; American Academy of Dermatology
07/05/2019
During Skin Cancer Awareness Month, the American Academy of Dermatology is asking the public “Do you use protection?” and encouraging consumers to “practice safe sun” — which includes applying sunscreen ROSEMONT, Ill., [...]
Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association
07/05/2019
Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association Switzerland, May 7, 2019: Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today [...]
Nelipak Healthcare Packaging and OPTEL Partner to Demonstrate New Seal Inspection Technology Concept for Vacuum-Formed Trays at MedtecLIVE 2019
07/05/2019
CRANSTON, R.I., May 07, 2019 (GLOBE NEWSWIRE) -- Nelipak ® Healthcare Packaging (“Nelipak”), a full-service global provider of custom thermoformed packaging that provides superior protection for medical devices and [...]
Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
07/05/2019
Top-line Data Readout on Target for early Q4 2019 LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative [...]
Sanofi : Dupixent® (dupilumab) Approved for Severe Asthma by European Commission
07/05/2019
Dupixent ® (dupilumab) Approved for Severe Asthma by European Commission Only biologic approved in the EU for severe asthma with type 2 inflammation, as characterized by raised blood eosinophils and/or raised fractional [...]
Sanofi : Dupixent® (dupilumab) approuvé dans le traitement de l'asthme sévère par la Commission européenne
07/05/2019
Dupixent ® (dupilumab) approuvé dans le traitement de l'asthme sévère par la Commission européenne Seul médicament biologique approuvé dans l'UE pour le traitement de l'asthme sévère avec inflammation de type 2 [...]
Auris Medical Reaches Midpoint for Enrollment in AM-201 Phase 1b Proof-of-Concept Study in Antipsychotic-Induced Weight Gain
07/05/2019
Hamilton, Bermuda, May 07, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]
CareDx’s AlloSeq cfDNA and QTYPE Solutions Featured at EFI 2019
07/05/2019
CareDx leadership in transplant innovation highlighted through multiple podium and poster presentations BRISBANE, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics [...]
CohBar Appoints Steven B. Engle as Chief Executive Officer
07/05/2019
MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy [...]
Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update
07/05/2019
SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various [...]
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019
07/05/2019
Conference Call Scheduled for Tuesday, May 14, 2019 at 9:00 AM ET PORTLAND, Maine, May 07, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company [...]
TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis at the American Academy of Neurology 71st Annual Meeting
07/05/2019
Ublituximab treatment continues to be well tolerated with a median duration of follow-up of 97.5 weeks NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company [...]
Global Kinetics Corporation’s PKG® Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication Optimization, and Patient-Clinician Conversations in Parkinson’s Disease
07/05/2019
Data Recently Presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical Study Continues Enrollment at 10 Movement Disorder Clinics in the U.S. PORTSMOUTH, N.H. and LONDON and MELBOURNE, [...]
Driven Deliveries Inc. to Present at The MoneyShow in Las Vegas On May 13th 2019
07/05/2019
Management will also participate in Panel Discussion. Investing in Cannabis SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (DRVD), the world’s first publicly traded cannabis delivery company, [...]
CV Sciences, Inc. to Present at Upcoming Investor Conferences
07/05/2019
LAS VEGAS, May 07, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating [...]
Akcea and Ionis Announce Approval of WAYLIVRA® (volanesorsen) in the European Union
07/05/2019
WAYLIVRA is the only therapy for Familial Chylomicronemia Syndrome, or FCS, a devastating, ultra-rare disease BOSTON and CARLSBAD, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an [...]

Pages